Stewardship Financial Corporation Reports Third Quarter of 2017 Earnings
Nov 07, 2017 21:07 pm UTC| Business
MIDLAND PARK, N.J., Nov. 07, 2017 -- Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, announced improved results for the current year periods. Net income for the three and...
Enphase Energy Reports Financial Results for the Third Quarter of 2017
Nov 07, 2017 21:07 pm UTC| Business
PETALUMA, Calif., Nov. 07, 2017 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world’s leading supplier of solar microinverters, announced today financial results for the third quarter...
Integer Announces Term B Loan Repricing and Third Amendment to Credit Agreement
Nov 07, 2017 21:07 pm UTC| Business
FRISCO, Texas, Nov. 07, 2017 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that it has completed a third amendment to its senior secured credit...
Renewable Energy Group Reports Third Quarter 2017 Financial Results
Nov 07, 2017 21:07 pm UTC| Business
Q3 2017 Highlights 152 million gallons sold, down 7% y/y120 million gallons produced, up 5% y/yNet loss of $11.4 million or $0.29 per shareAdjusted EBITDA of negative $1.5 millionAs of September 30, 2017:° Cash and cash...
Mitek Reports 31% Annual Revenue Growth and Increased Profitability for Fiscal 2017
Nov 07, 2017 21:07 pm UTC| Business
SAN DIEGO, Nov. 07, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and digital identity verification software solutions, today announced its financial results for the fourth...
Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nov 07, 2017 21:07 pm UTC| Business
DUBLIN, Ireland, Nov. 07, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
TRACON Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
Nov 07, 2017 21:06 pm UTC| Business
SAN DIEGO, Nov. 07, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update